Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population-Reference-Cited by-同舟云学术

Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population

Published:2023-05 Issue:5 Volume:42 Page:112501
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Stellas Dimitris,Karaliota Sevasti,Stravokefalou Vasiliki,Angel Matthew,Nagy Bethany A.,Goldfarbmuren Katherine C.,Bergamaschi Cristina,Felber Barbara K.,Pavlakis George N.^ORCID

Funder

National Cancer Institute

Novartis

Novartis Pharmaceuticals Corporation

Government of South Australia

Leidos Inc

National Institutes of Health

U.S. Department of Health and Human Services

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference119 articles.

1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007

2. Cancer statistics;Siegel;CA A Cancer J. Clin.,2018

3. Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody-drug conjugates and bispecific antibodies;Torres;Breast Cancer Res. Treat.,2022

4. Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers;Loi;J. Clin. Oncol.,2019

5. Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer;Criscitiello;Cancer Treat Rev.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-08-30

2. Resident memory T cells and cancer;Immunity;2024-08

3. First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors;Journal for ImmunoTherapy of Cancer;2023-10